Track Medtech Start-ups

Learn More
innovation hub

Glaukos (NASDAQ: GKOS) is Profiled in this Database

Updated At 01 May, 2019

Start Free 7 Day Trial Now
Partial description of this company
Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Glaukos (NASDAQ: GKOS) plus 4750 other startups.

Start Free 7 Day Trial Now

Learn More About Glaukos (NASDAQ: GKOS)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

More

Our Clients